Exploratory study on exogenous progesterone dosing and administration route in artificial endometrial preparation cycles

Phase 2, open-label trial of progesterone in female infertility (4 arms), sponsored by IVI Valencia. Primary endpoints: Whole-transcriptome gene expression related to progesterone treatment response in the window of implantation and Number of differentially expressed genes between progesterone treatment groups and natural cycle. Started Jul 2024; status: completed.